<DOC>
	<DOCNO>NCT00367094</DOCNO>
	<brief_summary>This study evaluate efficacy safety data benazepril/hydrochlorothiazide adult Chinese patient mild moderate essential hypertension . Patients whose blood pressure adequately control benazepril monotherapy 4 week run-in period randomly allocate double blind treatment 8 week either combination benazepril/hydrochlorothiazide per day continuation benazepril per day .</brief_summary>
	<brief_title>Combination Benazepril Plus Hydrochlorothiazide Chinese Patients With Mild Moderate Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male female patient , age 18 old Given inform consent Diagnosed mild moderate essential hypertension Severe hypertension Significant preexist cardiovascular cerebrovascular disease Diabetes mellitus type 1 poorly control diabetes mellitus type II Advanced renal impairment Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Hypertension , benazepril , hydrochlorothiazide , fix combination</keyword>
</DOC>